Skip to content

Predicting MRI Abnormalities With Longitudinal Data of the Whitehall II Substudy

Predicting MRI Abnormalities With Longitudinal Data of the Whitehall II Substudy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03335696
Enrollment
800
Registered
2017-11-08
Start date
2012-01-01
Completion date
2017-06-30
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affective Disorders, Cognitive Impairment, Dementia

Keywords

Epidemiology, Magnetic resonance imaging, Diffusion tensor imaging, White matter, Functional MRI, Connectome, Resting state brain networks, Neuropsychology

Brief summary

Follow-up study within the Whitehall II study, selecting 800 participants for further neuropsychological, clinical and imaging (MRI) examinations to examine brain structure and function in relation to age-related diseases and the modifiable and non-modifiable factors affecting resilience against and vulnerability to adverse brain changes.

Detailed description

A total of 6035 civil servants participated in the WHII Phase 11 clinical examination in 2012-2013. A random sample of 800 of these participants was included in a sub-study comprising an MRI brain scan, a detailed clinical and cognitive assessment, and collection of blood and buccal mucosal samples for the characterisation of immune function and associated measures. Data collection for this sub-study started in 2012 and was completed by in 2016. The participants, for whom social and health records have been collected since 1985, were between 60-85 years of age at the time the MRI study started. The pre-specified clinical and cognitive assessment protocols, the state-of-the-art MRI sequences and latest pipelines for analyses of this sub-study have been published and are attached to this application.

Interventions

None listed

Sponsors

University College, London
CollaboratorOTHER
University of Oxford
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Member of Whitehall II cohort attending at UCL for phase 11

Exclusion criteria

* Not suitable for MRI, travelling to Oxford, seriously physically ill

Design outcomes

Primary

MeasureTime frameDescription
Neuropsychological measure 12012-2016National Adult Reading Test (premorbid intellectual ability)
MRI Measures 22012-2016Siemens 3T - T1-weighted scan (MPRAGE) using FSL GLM Voxel based analysis for grey matter density analysis
Neuropsychological measure 22012-2016Montreal Cognitive Assessment (MoCA)
Neuropsychological measure 32012-2016Rey Complex Figure copy and delayed recall (visual episodic memory)
Neuropsychological measure 42012-2016Hopkins Verbal Learning Test Revised (verbal episodic memory)
Neuropsychological measure 52012-2016CANTAB Simple and Choice Reaction Time (processing speed)
Neuropsychological measure 62012-2016WAIS-R Digit Symbol Test (processing speed)
Neuropsychological measure 72012-2016Trail Making Test A and B (processing speed/executive functioning)
Neuropsychological measure 82012-2016WAIS-R Digit Span forward and backwards (executive functioning)
Neuropsychological measure 92012-2016Graded Naming Test (semantic memory)
MRI Measures 12012-2016Siemens 3T - T1-weighted scan (MPRAGE) using FSL FIRST, FAST, and Freesurfer Volume extractions
MRI Measures 32012-2016Siemens 3T - T2-weighted scan, clinical and FSL (BIANCA)-based rating of white matter changes
MRI Measures 42012-2016Siemens 3T Diffusion Tensor Images analyzed with Tract Based Spatial Statistics (TBSS)
MRI Measures 52012-2016Siemens 3T rs-fMRI analyzed with Multivariate Exploratory Linear Optimized Decomposition into Independent Components: MELODIC)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026